Methodological and ethical quality in phase III--breast cancer trials
- PMID: 20157975
Methodological and ethical quality in phase III--breast cancer trials
Abstract
Objective: The gold standard of Evidence Based Medicine remains the randomised controlled trial (RCT), which is the only tool that allows an approach to the "therapeutic truth". To reach credible conclusions, these trials need to be perfect in methodological and ethical quality. The purpose of this study is to evaluate methodological quality (MQ), ethical quality (EQ) and compliance with ethical requirements in phase III randomized clinical trials of breast cancer treatment.
Study design: MQ was evaluated by the Jadad-scale and EQ by the Berdeu-score for all the randomised controlled clinical trials (RCT) (n = 137), published between January 2001 and December 2005 in 11 international journals.
Results: Mean MQ was 9.88 +/- 1.43. MQ was insufficient (Jadad score pound 9) for 49 RCT (35,8%). Mean EQ was 0.45 +/- 0.12. Mean EQ for RCT with insufficient MQ (n = 49) was 0.43 +/- 0.12; Mean EQ for RCT with good MQ (Jadad score > 9)(n = 88) was 0.46 +/- 0.11. There was significant improvement in MQ depending on the year in which the study was started (p = 0.002). EQ was independent of the year of study's start (p = 0.134).There was no relationship between MQ or EQ and the number of patients included in the study (p = 0.53 and p = 0.1). There was a tendency towards correlation between MQ and EQ (p = 0.052), but the correlation between these two variables could not be considered as significant (r = 0.67). Informed consent from patients (ICP) was not obtained in 5.8% (n = 8) of the RCTs and the approval of a research ethics committee (REC) was not mentioned in 26.3% (n = 36) of the RCTs.
Conclusions: Good MQ and reporting of ethical requirements (EQ) reflects the respect shown to the patients during the whole research process. There are still deficiencies in EQ and MQ. Quality improvement requires education and appropriation by the scientific community, in particular, medical staff, of methodological and ethical basic rules concerning trials involving human beings.
Similar articles
-
Methodological and ethical quality of randomized controlled clinical trials in gastrointestinal surgery.J Gastrointest Surg. 2012 Sep;16(9):1758-67. doi: 10.1007/s11605-012-1952-0. Epub 2012 Jul 10. J Gastrointest Surg. 2012. PMID: 22777055
-
Methodological quality and reporting of ethical requirements in phase III cancer trials.J Med Ethics. 2005 May;31(5):251-5. doi: 10.1136/jme.2003.007435. J Med Ethics. 2005. PMID: 15863678 Free PMC article.
-
[Methodological and ethical quality in phase III cancer trials: role of the cooperative group].Bull Cancer. 2004 Oct;91(10):793-8. Bull Cancer. 2004. PMID: 15556880 French.
-
The quality of reporting of randomized controlled trials of traditional Chinese medicine: a survey of 13 randomly selected journals from mainland China.Clin Ther. 2007 Jul;29(7):1456-67. doi: 10.1016/j.clinthera.2007.07.023. Clin Ther. 2007. PMID: 17825697 Review.
-
Implications of socio-cultural contexts for the ethics of clinical trials.Health Technol Assess. 1997;1(9):i-iv, 1-65. Health Technol Assess. 1997. PMID: 9483158 Review.
Cited by
-
Methodological and ethical quality of randomized controlled clinical trials in gastrointestinal surgery.J Gastrointest Surg. 2012 Sep;16(9):1758-67. doi: 10.1007/s11605-012-1952-0. Epub 2012 Jul 10. J Gastrointest Surg. 2012. PMID: 22777055
MeSH terms
LinkOut - more resources
Medical